Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polymyalgia rheumatica and giant cell arteritis].

P Jipp, K Fehring

    Deutsche Medizinische Wochenschrift (1946)
    |October 26, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Polymyalgia rheumatica patients with temporal giant-cell arteritis face blindness risk. Headaches and neck/shoulder pain indicate higher danger, especially with mild general symptoms.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of antiestrogen treatment in a benign metastasizing leiomyoma with paraneoplastic estradiol production.

    Oncology reports·2011
    Same author

    [Risk factors for the development of vision disorders in polymyalgia rheumatica with giant cell arteritis].

    Deutsche medizinische Wochenschrift (1946)·2000
    Same author

    [The rare differential diagnosis of a mediastinal space-occupying lesion].

    Deutsche medizinische Wochenschrift (1946)·1999
    Same author

    Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).

    Hepato-gastroenterology·1998
    Same author

    [The synchronous occurrence of acute myeloid leukemia and kidney carcinoma].

    Deutsche medizinische Wochenschrift (1946)·1997
    Same author

    Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.

    Urologia internationalis·1997

    Area of Science:

    • Rheumatology
    • Ophthalmology